Current President and Head of Siemens Healthineers in The Americas Brings Strong Commercial Experience to the Board of Directors Karen Talmadge, Ph.D., Remains as Independent Board Member, Retaining Key Strengths and Experience for Gynesonics Redwood City, CA, June 7, 2021 – Gynesonics®, a women’s healthcare company focused on the development of minimally invasive solutions for […]
The national policy covers approximately 15 million lives in 48 states and Washington D.C. for this minimally invasive, uterine-preserving and incision-free treatment Redwood City, CA, June 3, 2021 – Gynesonics®, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, announced today that Cigna has released a national coverage […]
Additionally, an expert physician panel in Europe reached consensus and published a new recommended fibroid treatment algorithm with transcervical radiofrequency ablation (Sonata) at the forefront Redwood City, CA, June 1, 2021 – Gynesonics®, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, announced the publication of guidelines by […]
The initial results of the first 160 treated women in the Transcervical Radiofrequency Ablation of Uterine Fibroids Global Registry (SAGE) show the broad applicability of Transcervical Fibroid Ablation performed by the Sonata System to a wide range of fibroid types and sizes while maintaining an excellent safety profile Redwood City, CA, April 15, 2021 – […]
The analysis shows that fibroids, which are often treated by hysteroscopic resection or morcellation, can be effectively treated with the Sonata® System, the only incision-free, transcervical procedure that can treat most submucous, intramural, subserous, transmural and large fibroids REDWOOD CITY, CA, April 8, 2021 – Gynesonics®, a women’s healthcare company focused on the development of […]
Executive with Extensive Commercialization Experience to Provide Key Insights on Global Launch Strategies Redwood City, CA, March 18, 2021– Gynesonics®, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, announced today that medical device executive Susan Stimson has been appointed as an independent member to the company’s Board […]
HCSC is the largest customer-owned health insurer in the United States, operating Blue Cross and Blue Shield® Plans in Illinois, Montana, New Mexico, Oklahoma, and Texas Redwood City, CA, March 15, 2021 – Gynesonics®, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, announced today that Health Care […]
2021 Ruling Also Increases Hospital Outpatient Payment for the Associated Ambulatory Payment Classification That Covers the Sonata Treatment Redwood City, CA, March 9, 2021 – Gynesonics®, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, announced today that The Centers for Medicare and Medicaid Services (CMS) has included […]
Detroit Medical Center’s Danny Benjamin, M.D., FACOG, Chief of Obstetrics and Gynecology at DMC Huron Valley-Sinai Hospital, is the first to provide the uterus-preserving, outpatient treatment option to women in Michigan Redwood City, CA, January 21, 2021 – Gynesonics®, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, […]
MedStar Health is the first health system to provide Sonata, an incision-free, uterus-preserving, outpatient treatment option for women in the Maryland and Washington D.C. area Redwood City, CA – December 21, 2020 – Gynesonics®, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, announced today that MedStar Health, […]